Serum legacy and emerging PFAS and lipid biomarkers in patients with chronic coronary syndrome: a cross-sectional human biomonitoring study.
Per- and polyfluoroalkyl substances (PFAS) have been associated with altered lipid metabolism in general populations, but evidence remains limited among patients with established coronary artery disease, particularly for emerging PFAS replacement compounds. We conducted a cross-sectional study of 155 patients with chro...